Daré Bioscience prices USD 6 million registered direct offering at USD 1.37 per share

Reuters2026/08/17 12:36

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold. Trade now!

A welcome pack worth 6200 USDT for new users! Sign up now!

Daré Bioscience priced a registered direct offering of 4,379,581 common shares, or pre-funded warrants, at USD 1.37 per share.
Gross proceeds expected at closing: USD 6 million, before placement agent fees, commissions, and offering expenses.
Concurrent private placement includes Series A warrants, Series B warrants for up to 4,379,581 shares each; exercisability requires stockholder approval.
Series A warrants priced at USD 1.37, five-year term; Series B warrants priced at USD 1.37, two-year term.
Closing expected on or about Aug. 17, 2026, subject to customary closing conditions.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Dare Bioscience Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001493152-26-038649), on August 17, 2026, and is solely responsible for the information contained therein.

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.

Trade now！

Daré Bioscience prices USD 6 million registered direct offering at USD 1.37 per share

You may also like

Crypto prices